IN2013MU03124A - - Google Patents

Info

Publication number
IN2013MU03124A
IN2013MU03124A IN3124MU2013A IN2013MU03124A IN 2013MU03124 A IN2013MU03124 A IN 2013MU03124A IN 3124MU2013 A IN3124MU2013 A IN 3124MU2013A IN 2013MU03124 A IN2013MU03124 A IN 2013MU03124A
Authority
IN
India
Prior art keywords
insulin
metabolite
derivative
isoelectric point
analogue
Prior art date
Application number
Inventor
Maharaj K Sahib
Jeetendra Kashinath Ambulge
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN3124MU2013 priority Critical patent/IN2013MU03124A/en
Priority to US15/021,693 priority patent/US20160271226A1/en
Priority to AU2014326181A priority patent/AU2014326181A1/en
Priority to EP14799538.5A priority patent/EP3052114A1/en
Priority to BR112016006963A priority patent/BR112016006963A2/en
Priority to JP2016515453A priority patent/JP2016531847A/en
Priority to SG11201601477VA priority patent/SG11201601477VA/en
Priority to CN201480053586.6A priority patent/CN105579052A/en
Priority to RU2016107610A priority patent/RU2016107610A/en
Priority to PCT/IB2014/064922 priority patent/WO2015044922A1/en
Publication of IN2013MU03124A publication Critical patent/IN2013MU03124A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

The present invention discloses a composition comprising readily dissociable molecular aggregates formed by combining an insulin, insulin analogue, derivative or metabolite having isoelectric point between 5.8 to 8.5 in combination with one or more an insulin, insulin analogue, derivative or metabolite having isoelectric point between 4.0 to 5.7.
IN3124MU2013 2013-09-30 2014-09-29 IN2013MU03124A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IN3124MU2013 IN2013MU03124A (en) 2013-09-30 2014-09-29
US15/021,693 US20160271226A1 (en) 2013-09-30 2014-09-29 Pharmaceutical composition
AU2014326181A AU2014326181A1 (en) 2013-09-30 2014-09-29 Pharmaceutical composition
EP14799538.5A EP3052114A1 (en) 2013-09-30 2014-09-29 Pharmaceutical composition
BR112016006963A BR112016006963A2 (en) 2013-09-30 2014-09-29 pharmaceutical composition
JP2016515453A JP2016531847A (en) 2013-09-30 2014-09-29 Pharmaceutical composition
SG11201601477VA SG11201601477VA (en) 2013-09-30 2014-09-29 Pharmaceutical composition
CN201480053586.6A CN105579052A (en) 2013-09-30 2014-09-29 Pharmaceutical composition
RU2016107610A RU2016107610A (en) 2013-09-30 2014-09-29 PHARMACEUTICAL COMPOSITION
PCT/IB2014/064922 WO2015044922A1 (en) 2013-09-30 2014-09-29 Pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3124MU2013 IN2013MU03124A (en) 2013-09-30 2014-09-29

Publications (1)

Publication Number Publication Date
IN2013MU03124A true IN2013MU03124A (en) 2015-07-31

Family

ID=51903957

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3124MU2013 IN2013MU03124A (en) 2013-09-30 2014-09-29

Country Status (10)

Country Link
US (1) US20160271226A1 (en)
EP (1) EP3052114A1 (en)
JP (1) JP2016531847A (en)
CN (1) CN105579052A (en)
AU (1) AU2014326181A1 (en)
BR (1) BR112016006963A2 (en)
IN (1) IN2013MU03124A (en)
RU (1) RU2016107610A (en)
SG (1) SG11201601477VA (en)
WO (1) WO2015044922A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017145104A1 (en) 2016-02-25 2017-08-31 Wockhardt Limited Pharmaceutical composition of insulin glargine and amino acids
CN106729639B (en) * 2017-01-10 2018-02-27 鲁南制药集团股份有限公司 A kind of insulin glargine injecta and preparation method thereof
SG11202000625PA (en) * 2017-07-27 2020-02-27 Adocia Compositions in the form of an injectable aqueous solution comprising at least human insulin a21g and a prandial action glucagon suppressor
EP4007594A4 (en) * 2019-08-02 2023-08-09 Case Western Reserve University Premixed ultra-stable single-chain insulin analogue formulations
EP3915571A1 (en) * 2020-05-29 2021-12-01 Adocia Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action
EP3915572A1 (en) * 2020-05-29 2021-12-01 Adocia Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3316363A1 (en) 1983-05-05 1984-11-08 Deutsche Babcock Anlagen Ag, 4200 Oberhausen ROLLER GRID FOR WASTE COMBUSTION PLANTS
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DK257988D0 (en) 1988-05-11 1988-05-11 Novo Industri As NEW PEPTIDES
JPH04502465A (en) 1988-12-23 1992-05-07 ノボ　ノルディスク　アクティーゼルスカブ human insulin analogue
NZ232375A (en) 1989-02-09 1992-04-28 Lilly Co Eli Insulin analogues modified at b29
DK155690D0 (en) 1990-06-28 1990-06-28 Novo Nordisk As NEW PEPTIDES
JP2005526126A (en) * 2002-05-07 2005-09-02 ノボ　ノルディスク　アクティーゼルスカブ Soluble preparation containing insulin aspart and insulin detemia
KR101389226B1 (en) * 2005-05-23 2014-04-25 에스디지,인코포레이티드 Lipid Construct For Delivery Of Insulin To A Mammal
CA2609402C (en) * 2005-05-23 2014-10-21 Sdg, Inc. Lipid construct for delivery of insulin to a mammal
US8084420B2 (en) 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
US7713929B2 (en) * 2006-04-12 2010-05-11 Biodel Inc. Rapid acting and long acting insulin combination formulations
WO2007041481A1 (en) 2005-09-29 2007-04-12 Biodel, Inc. Rapid acting and prolonged acting insulin preparations
MX2008013165A (en) 2006-04-12 2009-01-29 Biodel Inc Rapid acting and long acting insulin combination formulations.
CN101454019A (en) * 2006-04-12 2009-06-10 百达尔公司 Rapid acting and long acting insulin combination formulations
US8575096B2 (en) * 2007-08-13 2013-11-05 Novo Nordisk A/S Rapid acting insulin analogues
JP2010535842A (en) 2007-08-13 2010-11-25 ノボ・ノルデイスク・エー／エス Fast-acting insulin analogue
WO2011094632A1 (en) 2010-01-29 2011-08-04 The Uab Research Foundation Method for administration of insulin and pharmaceutical composition thereof
EP2651432A1 (en) * 2010-12-14 2013-10-23 Novo Nordisk A/S Fast-acting insulin in combination with long-acting insulin
CA2843586A1 (en) 2011-08-10 2013-02-14 Adocia Injectable solution of at least one type of basal insulin

Also Published As

Publication number Publication date
EP3052114A1 (en) 2016-08-10
SG11201601477VA (en) 2016-04-28
RU2016107610A (en) 2017-11-03
CN105579052A (en) 2016-05-11
WO2015044922A1 (en) 2015-04-02
JP2016531847A (en) 2016-10-13
AU2014326181A1 (en) 2016-03-17
US20160271226A1 (en) 2016-09-22
BR112016006963A2 (en) 2017-08-01

Similar Documents

Publication Publication Date Title
MX2019010443A (en) Compositions and methods.
WO2014194034A3 (en) Novel metalloproteases
WO2015082046A3 (en) Substituted oxepines
IN2013MU03124A (en)
SG11201506149SA (en) Polyetheramines based on 1,3-dialcohols
WO2014206561A8 (en) Novel antibody frameworks
MX2019005151A (en) Pertuzumab variants and evaluation thereof.
PH12015502665A1 (en) Improvements in or relating to organic compounds
PL2984076T3 (en) 2,5-tetrahydrofurane-esters and -ethers as plasticizers
MX2016004885A (en) Functionalized polymer composition.
ECSDI15014919S (en) EXTENSION POLE MECHANISM FOR PAINT ROLLER
Shotton et al. Beyond the asterisk: Understanding Native American college students.
MX2015017638A (en) Tannin-containing polyols, their production and use.
EP2985017A4 (en) 1,2-alkane polyol-containing composition
SG10201401301UA (en) Conjugated diene based polymer, and polymer composition containing the polymer
SG10201400571XA (en) Conjugated diene based polymer, and polymer composition containing the polymer
SG10201400572VA (en) Conjugated diene based polymer, and polymer composition containing the polymer
JP2014189771A5 (en)
Jelinek Theatertexte
MX366815B (en) Polyols, production and use thereof.
ލިޔުންތެރިން ފަލަޞްޠީން-ޤުރުއާނާއި ސުންނަތުން
حسینی مهر et al. بررسی وضعیت مولفه های کفایت اجتماعی در طراحی برنامه درسی پایه ششم ابتدایی از منظر معلمان
Leuckart Musikalien-Verlags-Katalog FEC Leuckart, Leipzig: alphabetisch-systematisch vollständig bis Ende 1913.
AU2013904153A0 (en) Improved Objects Type 4.
UA97535U (en) SORBING-FILTERING MATERIAL